Vertex Pharmaceuticals Inc. (VRTX)

Index: Nasdaq 100
2.00%
$1.88
$95.77
02:17 26/07/16
$95.77
02:17 26/07/16
DAILY VARIATION
2.00%
$1.88
VOLUME
1,911,970
DATA
52 Week High
$141.48
52 Week Low
$78.40
Shares Issued
247.35m
Market Cap
$23,688.70m
RiskGrade
195
Beta
1.50
MENU

Vertex Pharmaceuticals Inc. Overview

Vertex Pharmaceuticals Incorportated in a United States-based drug manufacturer. The company focuses on the research and development of small molecule drugs that are used in the treatment of diseases, including HIV infection & chronic hepatitis C virus.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -45.2% 2.4%
ROCE 0.0%
Latest F'cast
P/E 41.5 9,483.8
PEG -1.6 -1.7
Pr/Revenue 22.9 13.2
Pr/Book 21.7
Latest F'cast
Revenue 77.9% -32.8%
PBT 0.0% n/a
EPS -26.4% -69.0%
DPS n/a 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2011-12-31 1,410.63 60.44 14.00¢ 237.2 0.0 n/a n/a 0.0%
2012-12-31 1,527.04 -12.38 -50.00¢ -83.8 0.0 n/a n/a 0.0%
2013-12-31 1,211.97 -626.04 -198.00¢ -37.5 0.0 n/a n/a 0.0%
2014-12-31 580.41 -734.88 314.00¢ 37.8 0.0 n/a n/a 0.0%
2015-12-31 1,032.34 -557.80 231.00¢ 54.5 -2.1 -26% n/a 0.0%

Forecast

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2016-12-31 1,791.57 43.70 107.19c 9,483.8 -177.0 -54% 0.00c 0.0%
2017-12-31 2,512.85 702.02 325.11c 2,786.1 13.7 203% 0.00c 0.0%

Regulatory News

No results found

Newspaper Links

No results found
No results found